Elaine Hoffman

15.0k total citations · 3 hit papers
64 papers, 10.6k citations indexed

About

Elaine Hoffman is a scholar working on Cardiology and Cardiovascular Medicine, Health, Toxicology and Mutagenesis and Physiology. According to data from OpenAlex, Elaine Hoffman has authored 64 papers receiving a total of 10.6k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Cardiology and Cardiovascular Medicine, 14 papers in Health, Toxicology and Mutagenesis and 13 papers in Physiology. Recurrent topics in Elaine Hoffman's work include Asthma and respiratory diseases (13 papers), Allergic Rhinitis and Sensitization (8 papers) and Arsenic contamination and mitigation (7 papers). Elaine Hoffman is often cited by papers focused on Asthma and respiratory diseases (13 papers), Allergic Rhinitis and Sensitization (8 papers) and Arsenic contamination and mitigation (7 papers). Elaine Hoffman collaborates with scholars based in United States, Canada and Japan. Elaine Hoffman's co-authors include Eugene Braunwald, Robert P. Giugliano, Christian T. Ruff, Naveen Deenadayalu, Elliott M. Antman, Alexander Parkhomenko, Jeffrey I. Weitz, Basil S. Lewis, Takeshi Yamashita and A. John Camm and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Elaine Hoffman

63 papers receiving 10.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials

2013 3.3k citations Robert P. Giugliano, Elaine Hoffman et al. The Lancet profile →
Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus

2013 2.5k citations Deepak L. Bhatt, Philippe Gabríel Steg et al. profile →
Efficacy, safety, and tolerability of a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 in combination with a statin in patients with hypercholesterolaemia (LAPLACE-TIMI 57): a randomised, placebo-controlled, dose-ranging, phase 2 study

2012 354 citations Robert P. Giugliano, Nihar R. Desai et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Elaine Hoffman United States	38	4.5k	2.5k	1.9k	1.3k	1.3k	64	10.6k
Geoffrey H. Tofler Australia	57	6.9k 1.5×	1.7k 0.7×	1.8k 1.0×	521 0.4×	851 0.7×	199	13.6k
Inger Njølstad Norway	52	3.5k 0.8×	1.3k 0.5×	1.3k 0.7×	1.1k 0.9×	761 0.6×	214	9.8k
Jean Ferrières France	64	6.5k 1.4×	2.9k 1.1×	4.0k 2.1×	511 0.4×	1.7k 1.3×	524	15.5k
Justin A. Ezekowitz Canada	60	11.3k 2.5×	1.5k 0.6×	1.6k 0.8×	502 0.4×	1.2k 0.9×	415	15.8k
A. Richey Sharrett United States	53	4.0k 0.9×	1.3k 0.5×	2.8k 1.5×	305 0.2×	477 0.4×	154	10.2k
Roberto Elosúa Spain	63	5.9k 1.3×	2.0k 0.8×	2.3k 1.2×	224 0.2×	1.4k 1.1×	370	13.8k
Nicholas L. Smith United States	48	2.1k 0.5×	1.6k 0.6×	772 0.4×	669 0.5×	653 0.5×	187	6.8k
Halit Silbershatz United States	24	8.4k 1.9×	3.1k 1.2×	3.4k 1.8×	510 0.4×	897 0.7×	32	15.9k
Bo Hedblad Sweden	69	5.4k 1.2×	2.3k 0.9×	2.2k 1.2×	268 0.2×	2.0k 1.5×	281	15.8k
Reinhold Kreutz Germany	48	5.7k 1.3×	2.6k 1.0×	1.3k 0.7×	791 0.6×	1.8k 1.4×	398	11.0k

Countries citing papers authored by Elaine Hoffman

Since Specialization

Citations

This map shows the geographic impact of Elaine Hoffman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elaine Hoffman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elaine Hoffman more than expected).

Fields of papers citing papers by Elaine Hoffman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elaine Hoffman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elaine Hoffman. The network helps show where Elaine Hoffman may publish in the future.

Co-authorship network of co-authors of Elaine Hoffman

This figure shows the co-authorship network connecting the top 25 collaborators of Elaine Hoffman. A scholar is included among the top collaborators of Elaine Hoffman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elaine Hoffman. Elaine Hoffman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zerbini, Cristiano A. F., S. Radominski, Mario H. Cardiel, et al.. (2016). Efficacy and Safety of Tofacitinib Monotherapy Versus Combination Therapy in a Latin American Subpopulation of Patients with Rheumatoid Arthritis: A Pooled Phase 3 Analysis. JCR Journal of Clinical Rheumatology. 1 indexed citations

Zerbini, Cristiano A. F., Mario H. Cardiel, Gustavo Citera, et al.. (2016). Herpes zoster in patients with rheumatoid arthritis: pooled analyses of tofacitinib phase 2, 3 and long-term extension studies in a Latin American subpopulation. Universidad de Chile. 1 indexed citations

O’Donoghue, Michelle L., David A. Morrow, Sotirios Tsimikas, et al.. (2013). Lipoprotein(a) for Risk Assessment in Patients With Established Coronary Artery Disease. Journal of the American College of Cardiology. 63(6). 520–527. 155 indexed citations

Tse, Sze Man, Diane R. Gold, Joanne E. Sordillo, et al.. (2013). Diagnostic accuracy of the bronchodilator response in children. Journal of Allergy and Clinical Immunology. 132(3). 554–559.e5. 65 indexed citations

Kohli, Payal, Philippe Gabríel Steg, Sidney C. Smith, et al.. (2013). NSAID Use and Association with Cardiovascular Outcomes in Outpatients with Stable Atherothrombotic Disease. The American Journal of Medicine. 127(1). 53–60.e1. 45 indexed citations

Smith, Donald R., Elaine Hoffman, Manish Arora, et al.. (2012). S-039. Epidemiology. 23. 1–1. 1 indexed citations

Sarma, Amy, Stephen D. Wiviott, Elliott M. Antman, et al.. (2012). Abstract 17455: Pharmacodynamic Response to Clopidogrel in Men versus Women: Insights from the PRINCIPLE-TIMI 44 Trial. Circulation. 126(1). 55–9. 1 indexed citations

Sheehan, William J., Elaine Hoffman, Chunxia Fu, et al.. (2012). Endotoxin exposure in inner-city schools and homes of children with asthma. Annals of Allergy Asthma & Immunology. 108(6). 418–422. 37 indexed citations

Braun, Joe M., Roberto G. Lucchini, David C. Bellinger, et al.. (2012). Predictors of virtual radial arm maze performance in adolescent Italian children. NeuroToxicology. 33(5). 1203–1211. 10 indexed citations

10.

Rao, Devika, Jonathan M. Gaffin, Sachin N. Baxi, et al.. (2012). The Utility of Forced Expiratory Flow between 25% and 75% of Vital Capacity in Predicting Childhood Asthma Morbidity and Severity. Journal of Asthma. 49(6). 586–592. 105 indexed citations

11.

Bartnikas, Lisa M., William J. Sheehan, Elaine Hoffman, et al.. (2012). Predicting food challenge outcomes for baked milk: role of specific IgE and skin prick testing. Annals of Allergy Asthma & Immunology. 109(5). 309–313.e1. 58 indexed citations

12.

Giugliano, Robert P., Nihar R. Desai, Payal Kohli, et al.. (2012). Efficacy, safety, and tolerability of a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 in combination with a statin in patients with hypercholesterolaemia (LAPLACE-TIMI 57): a randomised, placebo-controlled, dose-ranging, phase 2 study. The Lancet. 380(9858). 2007–2017. 354 indexed citations breakdown →

13.

Braun, Joe M., Elaine Hoffman, Joel Schwartz, et al.. (2012). Assessing windows of susceptibility to lead-induced cognitive deficits in Mexican children. NeuroToxicology. 33(5). 1040–1047. 47 indexed citations

14.

Permaul, Perdita, Elaine Hoffman, Chunxia Fu, et al.. (2012). Allergens in urban schools and homes of children with asthma. Pediatric Allergy and Immunology. 23(6). 543–549. 78 indexed citations

15.

Dennerlein, Jack T., et al.. (2011). Is renovation riskier than new construction? An observational comparison of risk factors for stepladder‐related falls. American Journal of Industrial Medicine. 54(8). 579–585. 7 indexed citations

16.

Sordillo, Joanne E., et al.. (2010). Home Characteristics as Predictors of Bacterial and Fungal Microbial Biomarkers in House Dust. Environmental Health Perspectives. 119(2). 189–195. 60 indexed citations

17.

Sordillo, Joanne E., Elaine Hoffman, Juan C. Celedón, et al.. (2010). Multiple microbial exposures in the home may protect against asthma or allergy in childhood. Clinical & Experimental Allergy. 40(6). 902–910. 64 indexed citations

18.

Breton, Carrie V., Molly L. Kile, Paul J. Catalano, et al.. (2007). GSTM1 and APE1 genotypes affect arsenic-induced oxidative stress: a repeated measures study. Environmental Health. 6(1). 39–39. 33 indexed citations

19.

Lieberman, Jeffrey A., Miranda Chakos, José Alvir, et al.. (2001). Longitudinal study of brain morphology in first episode schizophrenia. Biological Psychiatry. 49(6). 487–499. 389 indexed citations

20.

Chakos, Miranda, J.A. Lieberman, Elaine Hoffman, Daniel W. Bradford, & Brian Sheitman. (2001). Effectiveness of Second-Generation Antipsychotics in Patients With Treatment-Resistant Schizophrenia: A Review and Meta-Analysis of Randomized Trials. American Journal of Psychiatry. 158(4). 518–526. 484 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact